HSA-free formulations of interferonbeta

Details for Australian Patent Application No. 2002241769 (hide)

Owner Chiron Corporation

Inventors Choe, Minna; Babuka, Susan; Shirley, Bret A.; Hora, Maninder; Tellers, Melanie; Chen, Bao-Lu

Agent FB Rice

Pub. Number AU-B-2002241769

PCT Pub. Number WO2002/080976

Priority 10/035,397 25.10.01 US; 60/282,614 09.04.01 US; 60/330,404 18.10.01 US

Filing date 26 October 2001

Wipo publication date 21 October 2002

Acceptance publication date 1 June 2006

International Classifications

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002241769

4 March 2004 Amendment Made

  The nature of the amendment is: Add the following co-inventors: Chen, Bao-Lu and Hora, Maninder.

1 June 2006 Application Accepted

  Published as AU-B-2002241769

21 September 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 04 Sep 2006. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street MELBOURNE VIC 3000

28 September 2006 Standard Patent Sealed

22 February 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Sep 2006

31 January 2008 Assignment Registered

  Chiron Corporation The patent has been assigned to Novartis Vaccines and Diagnostic Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002241770

2002241768-Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase